Parexel: Clinical Trials

13 trials sponsored by Parexel, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

10 completed, 1 recruiting, 1 terminated, 1 withdrawn. 13 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	13	Completed 10, Recruiting 1, Terminated 1, Withdrawn 1

Follow Parexel: new trials by email

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation Budesonide/Glycopyrronium/Formoterol Fumarate, Placebo, Metered dose inhaler - Chronic Obstructive Pulmonary Disease, Hyperinflation	Phase 4	Recruiting	AstraZeneca	56	2025-11-24	2026-09-18
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States Tezepelumab - Asthma	Phase 4	Completed	AstraZeneca	286	2022-04-29	2026-07-16
A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD) Roxadustat, rHuEPO - Anemia of Chronic Kidney Disease	Phase 4	Completed	AstraZeneca	25	2021-02-22	2024-04-22
Durvalumab Long-Term Safety and Efficacy Study Durvalumab - Solid Tumor	Phase 4	Completed	AstraZeneca	163	2019-09-05	2024-12-20
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) FF/UMEC/VI, Tiotropium, Albuterol/salbutamol - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	800	2018-03-29	2021-07-15
The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma Fluticasone Furoate/Vilanterol, Fluticasone Furoate, Salbutamol/Albuterol - Asthma	Phase 4	Withdrawn	GlaxoSmithKline		2018-03-07	2018-01-29
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate Certolizumab Pegol (CZP), Adalimumab (ADA), Methotrexate (MTX) - Rheumatoid Arthritis	Phase 4	Completed	UCB Pharma SA	915	2011-12-01	2018-07-31
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. ADVAIR 100/50mcg, ADVAIR 250/50mcg, ADVAIR 500/50mcg - Asthma	Phase 4	Completed	GlaxoSmithKline	11751	2011-11-18	2018-08-06
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old ADVAIR 100/50mcg, ADVAIR 250/50mcg, FLOVENT 100mcg - Asthma	Phase 4	Completed	GlaxoSmithKline	6250	2011-11-17	2018-08-06
Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients Levetiracetam 250 mg, Levetiracetam 500 mg - Healthy Subjects, Renal Impairments	Phase 4	Completed	UCB Pharma	30	2011-11-01	2014-02-10
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole esomeprazole 20 mg - Gastroesophageal Reflux Disease, GERD	Phase 4	Completed	AstraZeneca	107	2011-08-01	2013-02-21
Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients mycophenolate mofetil (Myfenax), mycophenolate mofetil (Cellcept) - Stable Renal Transplant Recipients	Phase 4	Terminated	Teva Branded Pharmaceutical Products R&D, Inc.	43	2009-08-01	2018-11-08
Dalacin-T Gel Post Approval Study clindamycin, nadifloxacin - Acne Vulgaris	Phase 4	Completed	Pfizer	134	2005-01-01	2011-05-11

Conditions studied

Interventions

Countries

Top investigators

Results publications

NIH funding